TABLE 2.
Producer cellb | Permeabilizing agent | Effect(s) of vif inactivation on DNA synthesis | Reference |
---|---|---|---|
SupT1 | 1 mM β-octylglucoside | No effect | 76 |
Jurkat | None; analysis of cDNA in purified virions | No effect | 49 |
CEM | None; analysis of cDNA in purified virions | No effect | 234 |
CEM | 1 mM β-octylglucoside | >5-fold decrease in levels of early as well as full length products | 76 |
Different chronically infected H9 clones with different levels of restrictionc | 0.01 to 0.5% Nonidet P-40 | Strong global defect correlated with the defect in intracellular reverse transcription | 163 |
H9 | None | No or little effect | 55 |
H9 | Melittin | Slight defect | 55 |
H9 | 0.01% Triton X-100 | Strong defect; no long double-stranded DNA products | 55 |
H9 | 0.02% Triton X-100 | 8-fold decrease of nucleotide incorporation | 49 |
H9 | None; analysis of cDNA in purified virions | ∼8-fold decrease in reverse transcription (similar effect on products of different lengths) | 49 |
H9 or HUT78 | Melittin | ∼1.8-fold reduction | 173 |
H9 or HUT78 | 0.01-0.04% Triton X-100 or Nonidet P-40 | ∼1.8-fold reduction | 173 |
HUT78 | Melittin | ∼1.5-fold reduction | 68 |
Virions produced by permissive and nonpermissive cells were purified, and the efficiencies of reverse transcription inside HIV-1 vif+ and Δvif virions were compared. Virions were either untreated or treated with different permeabilizing agents to facilitate the penetration of the dNTPs.
Permissive and nonpermissive cells are indicated in boldface type and with underlining, respectively.
Those authors compared levels of DNA synthesis by isogenic HIV-1 Vif− mutants produced by different chronically infected H9 clones, which exhibit different degrees of impairment in their replicative capacity (163).